Author: Editor

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Medhavi Gupta discusses symptoms that may be seen in patients with breast cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis. In this video, Dr. Medhavi Gupta examines the steps a patient could go through after an abnormality is found on a breast cancer screening. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Medhavi Gupta discusses mammograms, ultrasounds, and MRIs for breast cancer screening. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Medhavi Gupta discusses how common breast cancer is, and why it is crucial to get screened. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis. In this video, Dr. Rana McKay discusses why it’s crucial to get a prostate cancer screening. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das examines the importance of patient centered care, including safety throughout the process, and equitable care for all. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das discusses the importance of staging of cancer, and of testing for mutations. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das discusses the importance of staging of cancer, and of testing for mutations. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das examines the first domain of quality cancer care: finding the cancer early. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das talks about goals for lung cancer advocacy, including broader testing. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das discusses comprehensive care in lung cancer, and who is involved from screening to treatment. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das explains the process of getting a lung cancer screening. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das discusses which patients should receive lung cancer screening. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University of Alabama Birmingham; Dr. Rana McKay, Medical Oncologist, Associate Professor of Medicine, UC San Diego; and Dr. Medhavi Gupta, Hematologist-Oncologist, Roswell Park Comprehensive Cancer Center, Assistant Professor of Medicine, Brown University, present the importance about Testing and Early Diagnosis for Lung Cancer. In this video, Dr. Devika Das gives a brief overview of the importance of lung cancer screening during a pandemic. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch discusses the importance of biomarker testing, as well as disparities that exist in the field. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch examines liquid biopsies and their current and future role in diagnosis. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch discusses the ALK, RET, and MET mutations. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an important decision about hormone therapy. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss resources for patients with cancer. For a full list of resources, please visit the cancerGRACE site at https://cancergrace.org/video-collection/patient-education-ambassador-program, or see these links, below: Making Cancer Decisions – https://www.cancer.net/navigating-cancer-care/how-cancer-treated/making-decisions-about-cancer-treatment UCSF’s Advanced Prostate Cancer Patient Guide – https://urology.ucsf.edu/sites/urology.ucsf.edu/files/uploaded-files/attachments/sduro0215_advanced_prostate_cancer_and_its_treatment-a_patient_guide.pdf Non-profit organizations – Prostate Cancer Foundation – https://www.pcf.org/ – American Society of Clinical Oncology – https://www.cancer.net/…

For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an important decision about hormone therapy. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss personal preferences in the decision-making process. For resources and tools, please see the links available in the description of the last video in this series, or visit the cancerGRACE site at https://cancergrace.org/video-collection/patient-education-ambassador-program For more, please visit https://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. #prostatecancer #cancer #cancerresources #exelixis #lilly #genentech #hormonetherapy

For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an important decision about hormone therapy. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss the option of waiting to start hormone treatment. For resources and tools, please see the links available in the description of the last video in this series, or visit the cancerGRACE site at https://cancergrace.org/video-collection/patient-education-ambassador-program For more, please visit https://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. #prostatecancer #cancer #cancerresources #exelixis #lilly #genentech #hormonetherapy

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch looks at KRAS mutations in advanced disease. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch talks briefly about Exon 20, and the importance of the Destiny Trial for patients with HER2. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch discusses the ADAURA Trial, which tested Osimertinib for early stage EGFR+ NSCLC. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch looks at the drug combination of Amivantamab and Lazertinib in EGFR MET+ disease. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch discusses options when a patient with EGFR+ NSCLC develops acquired resistance to Osimertinib. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an important decision about hormone therapy. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss his first option: starting hormone treatment immediately and its risks/benefits. For resources and tools, please see the links available in the description of the last video in this series, or visit the cancerGRACE site at https://cancergrace.org/video-collection/patient-education-ambassador-program For more, please visit https://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. #prostatecancer #cancer #cancerresources #exelixis #lilly…

For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an important decision about hormone therapy. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss his treatment options for prostate cancer: starting androgen deprivation therapy immediately versus later. For resources and tools, please see the links available in the description of the last video in this series, or visit the cancerGRACE site at https://cancergrace.org/video-collection/patient-education-ambassador-program #prostatecancer #cancer #cancerresources #exelixis #lilly #genentech #hormonetherapy For more, please visit https://cancerGRACE.org/. To…

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch examines treatment options for EGFR+ NSCLC. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch discusses the advantages of Next Generation Sequencing. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch examines the concept of targeted driver mutations in NSCLC treatment. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer. In this video, Dr. Fred Hirsch talks about the changes in the first-line treatment of metastatic NSCLC over the past 2 decades. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. Drs. Sheth and Gold examine a drug that treats oral mucositis. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. Drs. Sheth and Gold look at the importance of CT and HPV DNA in treatment of head and neck cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. Drs. Sheth and Gold examine possible treatment combinations for head and neck cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. Drs. Sheth and Gold discuss how to treat patients with recurrent or metastatic head and neck cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. Drs. Sheth and Gold talk about the effectiveness of immunotherapy in head and neck cancer treatment. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. In this video, Drs. Sheth and Gold examine the benefit of weekly cisplatin usage for patients with head and neck cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

In this video series Dr. Kathryn Gold, Medical Oncologist specializing in lung, head and neck cancers, Professor with the Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology at UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022. Drs. Sheth and Gold discuss emerging information on deintensification for nasopharyngeal cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

El Dr. Eric Singh, uno de los participantes en el Programa de Embajadores de Educación para Pacientes GRACE del año pasado, produjo este excelente video para nuestra comunidad de habla hispana, sobre visitas de oncología médica. Este video proporciona una guía del paciente para la visita inicial de oncología médica. Para descargar las notas útiles del Dr. Singh, visite https://cancergrace.org/video-collection/patient-education-ambassador-program, https://cancergrace.org/sites/default/files/2022-08/GUIÏA%20DEL%20PACIENTE%20PARA%20LA%20VISITA%20INICIAL%20DE%20ONCOLOGIÏA%20MEÏDICA_Spanish.pdf Para obtener más información, visite http://cancerGRACE.org/. Para unirse a la conversación, visite https://cancergrace.org/forum.

Dr. Eric Singh, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video for our English-speaking community, on medical oncology visits. This video provides a patient’s guide to the initial medical oncology visit. To download Dr. Singh’s helpful notes, please visit https://cancergrace.org/video-collection/patient-education-ambassador-program and https://cancergrace.org/sites/default/files/2022-08/Patient%20Guide%20to%20Initial%20Medical%20Oncology%20Visit_English.pdf. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes look at the Checkmate 816 study, which examined chemo combined with Opdivo in patients with 1B to 3A disease. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes discuss the results of the Skyscraper Trial, which looked at small cell lung cancer. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes examine the use of Patritumab Deruxtecan in patients without particular mutations. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes discuss the use of Durvalumab in patients with EGFRm+ NSCLC. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes discuss the use of Rybrevant/Lazertinib in patients with EGFRm+ acquired resistance. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes look at data that suggests patients with previously treated advanced NSCLC may respond to Keytruda combined with Anti-VEGF Treatment. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes discuss a study showing positive results for Adagrasib in previously treated disease. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video Drs. West, Naidoo, and Lopes examine an FDA analysis that states patients with a KRAS Mutation should opt for chemo and immunotherapy. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video, Drs. West, Naidoo, and Lopes discuss if patients with high PD-L1 should have immunotherapy alone, or combine with chemotherapy. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022. In this video, Drs. West, Naidoo, and Lopes discuss a study that showed overall survival increased with thorough molecular testing. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.